Renal programmed cell death and the treatment of renal disease

被引：0
|
作者：
Hammerman, MR
机构：
[1] Washington Univ, Sch Med, Dept Med, Renal Div,George M OBrien Kidney & Urol Dis Ctr, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
来源：
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 1998年 / 7卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [31] Death by design - Programmed cell death in cardiovascular biology and disease
    MacLellan, WR
    Schneider, MD
    CIRCULATION RESEARCH, 1997, 81 (02) : 137 - 144
  • [32] Role of renal tubular programed cell death in diabetic kidney disease
    Zhou, Xiaojun
    Xu, Chunmei
    Dong, Jianjun
    Liao, Lin
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (02)
  • [33] RENAL FUNCTION AND RENAL FAILURE - A PROGRAMMED TEXT
    BORRERO, J
    ARCHIVES OF INTERNAL MEDICINE, 1966, 117 (05) : 733 - +
  • [34] RENAL FUNCTION AND RENAL FAILURE - RENAL FUNCTION AND RENAL FAILURE - A PROGRAMMED TEXT
    LASKER, N
    ANNALS OF INTERNAL MEDICINE, 1966, 64 (03) : 731 - +
  • [35] Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma
    Mantia, Charlene M.
    McDermott, David F.
    CANCER, 2019, 125 (23) : 4148 - 4157
  • [36] Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitors
    Chen, Bo-Han
    Kao, Chien-Chang
    Xu, Ting
    Yang, Yung-Ning
    Cha, Tai-Lung
    Tsai, Yi-Ta
    Liu, Shu-Yu
    Wu, Sheng-Tang
    Meng, En
    Tsao, Chih-Wei
    Chen, Chin-Li
    Sun, Guang-Huan
    Yu, Dah-Shyong
    Chang, Sun-Yran
    Yang, Ming-Hsin
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (09) : 947 - 954
  • [37] Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
    Motohide Uemura
    Noboru Nakaigawa
    Naoto Sassa
    Katsunori Tatsugami
    Kenichi Harada
    Toshinari Yamasaki
    Nobuaki Matsubara
    Takuya Yoshimoto
    Yuki Nakagawa
    Tamaki Fukuyama
    Mototsugu Oya
    Nobuo Shinohara
    Hirotsugu Uemura
    Toyonori Tsuzuki
    International Journal of Clinical Oncology, 2021, 26 : 2073 - 2084
  • [38] Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
    Uemura, Motohide
    Nakaigawa, Noboru
    Sassa, Naoto
    Tatsugami, Katsunori
    Harada, Kenichi
    Yamasaki, Toshinari
    Matsubara, Nobuaki
    Yoshimoto, Takuya
    Nakagawa, Yuki
    Fukuyama, Tamaki
    Oya, Mototsugu
    Shinohara, Nobuo
    Uemura, Hirotsugu
    Tsuzuki, Toyonori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (11) : 2073 - 2084
  • [39] Axitinib Reverses Resistance to Anti-Programmed Cell Death-1 Therapy in a Patient With Renal Cell Carcinoma
    Yang, Yonghao
    Huang, Hao
    Li, Tiepeng
    Gao, Quanli
    Song, Yongping
    Wang, Zibing
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] Comparative analysis of programmed cell death ligand 1 (PD-L1) assays in renal cell carcinoma
    Shim, B.
    Lee, K. S.
    Yun, S.
    Lee, K.
    Moon, S.
    Choe, G.
    VIRCHOWS ARCHIV, 2019, 475 : S185 - S185
12345